Congestive lung diseases

Subsets of the hypertensive population The (3-blockers are more effective for treating hypertension in white than in black patients, and in young patients compared to the elderly. [Note Conditions that discourage the use of 3-blockers (for example, severe chronic obstructive lung disease, chronic congestive heart failure, severe symptomatic occlusive peripheral vascular disease) are more commonly found in the elderly and in diabetics.]... 

Sleep disorders associated with other chronic medical conditions, for example, asthma, chronic lung disease, cystic fibrosis, chronic pain, kidney and liver failure, congestive heart failure, gastroesophageal reflux, thyroid disorders, and menopause. 

Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002 39 202-9. 

Chronic inflammatory liver diseases Malignancies Carcinoma Lymphoma Leukemia Multiple myeloma Less common causes Alcoholic liver disease Congestive heart failure Thrombophlebitis Chronic obstructive lung disease Ischemic heart disease... 

Cardiomyopathy. Cardiomyopathy, or diseased heart muscle, may reach a point at which the heart can no longer function. It arises from a combination of factors, including hypertension, arrhythmias, and valve disease. Other problems, such as congestive heart failure, cause the interrelated heart—lung system to break down. Because the heart can no longer adequately pump, duid builds up in the lungs and other areas. 

Although heart disease commonly affects the entire myocardium, congestive heart failure is sometimes divided into left and right heart failure (Fig. 24—2). In left heart failure, the left atrium and ventricle are unable to adequately handle the blood returning from the lungs. This causes pressure to build up in the pulmonary veins, and fluid accumulates in the lungs. Consequently, left heart failure is associated with pulmonary edema (see Fig. 24—2 A). 

If the underlying disease causes cardiac function to deteriorate despite expansion of plasma volume, the kidney continues to retain salt and water, which then leaks from the vasculature and becomes interstitial or pulmonary edema. At this point, diuretic use becomes necessary to reduce the accumulation of edema, particularly that which is in the lungs. Reduction of pulmonary vascular congestion with diuretics may actually improve oxygenation and thereby improve myocardial function. Edema associated with heart failure is generally managed with loop diuretics. In some instances, salt and water retention may become so severe that a combination of thiazides and loop diuretics is necessary. 

Alter short-term therapy (some weeks), in CF patients with mild to moderate stable pulmonary disease, inhalation of rhDNase in combination with other CF therapies (eg., bronchodilators, pancreatic enzymes, chest physiotherapy) improves the lung function [64.70-72], The rhDNase therapy is also associated with significant improvements in general well-being, cough frequency, and congestion [71,72],... 

Immunological reactions to cromoglicate can involve the pericardium, the lung, the eye, the nasal mucosa, the skin, the joints, and the liver. Rarely, a hypersensitivity reaction can cause fever (4). A survey of the world literature up to 1982 found 13 cases of facial rash, urticaria, and/or generalized dermatitis, and one of nasal congestion. In 19 patients there was bronchospasm and/or pulmonary edema, eventually culminating in shock. Four cases of eosinophilic or granulomatous pulmonary infiltration, one of liver disease and vasculitis, one of pericarditis, and three of polymyositis were reported. 

---